Interim Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 30, 2022	Sep. 30, 2022
Current assets:
Cash and cash equivalents	$ 626,158	$ 620,127
Restricted cash	5,319	8,244
Short-term investments	132,875	189,213
Accounts receivable, net of allowance for credit losses of $11,173 and $11,834	289,597	243,593
Contract assets, net of allowance for credit losses of $148 and $125	215,923	176,093
Inventories, net	26,111	23,549
Prepaid expenses and other current assets	53,432	50,075
Total current assets	1,349,415	1,310,894
Long-term investments	124,024	102,514
Property, plant, and equipment, net	512,168	513,481
Operating lease right-of-use assets	43,355	46,530
Intangible assets, net	105,912	112,265
Goodwill	369,385	365,147
Other non-current assets	52,080	55,149
Deferred taxes	192,184	183,568
Total assets	2,748,523	2,689,548
Current liabilities:
Accounts payable	17,361	14,171
Accrued liabilities	230,346	230,237
Income taxes payable	7,183	1,265
Contract liabilities	22,356	18,588
Operating lease liabilities	13,201	13,257
Total current liabilities	290,447	277,518
Non-current contract liabilities	22,734	23,203
Non-current operating lease liabilities	34,221	37,685
Other non-current liabilities	108,596	100,122
Total liabilities	455,998	438,528
Stockholders’ equity:
Retained earnings	2,319,358	2,297,730
Accumulated other comprehensive loss	(31,875)	(51,641)
Total stockholders’ equity – Dolby Laboratories, Inc.	2,287,578	2,246,183
Controlling interest	4,947	4,837
Total stockholders’ equity	2,292,525	2,251,020
Total liabilities and stockholders’ equity	2,748,523	2,689,548
Class A, $0.001 par value, one vote per share, 500,000,000 shares authorized: 60,002,630 shares issued and outstanding at December 30, 2022 and 59,798,862 at September 30, 2022
Stockholders’ equity:
Common stock	54	53
Class B, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 36,085,779 shares issued and outstanding at December 30, 2022 and 36,085,779 at September 30, 2022
Stockholders’ equity:
Common stock	$ 41	$ 41